(Q43552410)

24 November 2017

title

Hamartin and tuberin expression in human tissues (English)

1 reference

24 November 2017

Johnson MW

1

1 reference

24 November 2017

Kerfoot C

2

1 reference

24 November 2017

Bushnell T

3

1 reference

24 November 2017

Li M

4

1 reference

24 November 2017

Vinters HV

5

1 reference

24 November 2017

publication date

1 March 2001

1 reference

24 November 2017

1 reference

24 November 2017

volume

14

1 reference

24 November 2017

issue

3

1 reference

24 November 2017

page(s)

202-210

1 reference

Diagnostic criteria: tuberous sclerosis complex. Report of the Diagnostic Criteria Committee of the National Tuberous Sclerosis Association

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880286

Phenotypes of the tuberous sclerosis complex with a revision of diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880286

Malignant tumors of the kidney, brain, and soft tissues in children and young adults with the tuberous sclerosis complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880286

Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880286

Identification of tuberin, the tuberous sclerosis-2 product. Tuberin possesses specific Rap1GAP activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880286

The tuberous sclerosis 2 gene product, tuberin, functions as a Rab5 GTPase activating protein (GAP) in modulating endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880286

Inactivation of the cyclin-dependent kinase inhibitor p27 upon loss of the tuberous sclerosis complex gene-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880286

Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880286

The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880286

Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880286

Tuberin immunohistochemistry in brain, kidneys and heart with or without tuberous sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880286

Cortical dysplasia, genetic abnormalities and neurocutaneous syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880286

Hamartin expression and interaction with tuberin in tumor cell lines and primary cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880286

The TSC1 gene product, hamartin, negatively regulates cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880286

Characterization of the cytosolic tuberin-hamartin complex. Tuberin is a cytosolic chaperone for hamartin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880286

Identification and characterization of the tuberous sclerosis gene on chromosome 16

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880286

7 January 2021

9q34 loss of heterozygosity in a tuberous sclerosis astrocytoma suggests a growth suppressor-like activity also for the TSC1 gene

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880286

7 January 2021

Distribution of Tsc2 protein in various normal rat tissues and renal tumours of Tsc2 mutant (Eker) rat detected by immunohistochemistry

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880286

7 January 2021

Co-localization of TSC1 and TSC2 gene products in tubers of patients with tuberous sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880286

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880286

7 January 2021

Lymphangiectasia within angiomyolipoma in a tuberous sclerosis patient

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880286

7 January 2021

Tuberous sclerosis associated with multiple hepatic lipomatous tumors and hemorrhagic renal angiomyolipoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880286

7 January 2021

Hepatic angiomyolipoma: a clinicopathologic study of 30 cases and delineation of unusual morphologic variants

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880286

7 January 2021

Gastrointestinal involvement in tuberous sclerosis. Two case reports

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880286

7 January 2021

Adenocarcinoma of the rectum with associated colorectal adenomatous polyps in tuberous sclerosis: a case report

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880286

7 January 2021

10.1038/MODPATHOL.3880286

Identifiers

DOI

1 reference

Dimensions Publication ID

24 November 2017

1001512702

0 references

1 reference